Dalfampridine effects on cognition, fatigue, and dexterity

Changes in Cognitive Processing Speed, Mood, and Fatigue in an Observational Study of Persons With Multiple Sclerosis Treated With Dalfampridine-ER

(2016) Elizabeth W. Triche et al.   CLINICAL NEUROPHARMACOLOGY

Effect of Fampridine-PR (prolonged released 4-aminopyridine) on the manual functions of patients with Multiple Sclerosis

(2016) Ziv Savin et al.   JOURNAL OF THE NEUROLOGICAL SCIENCES

Short-term impact of fampridine on motor and cognitive functions, mood and quality of life among multiple sclerosis patients

(2015) Katja Pavsic et al.   CLINICAL NEUROLOGY AND NEUROSURGERY

Verbal Fluencies and Fampridine Treatment in Multiple Sclerosis

(2015) Eloi Magnin et al.   EUROPEAN NEUROLOGY

Sustained-released fampridine in multiple sclerosis: effects on gait parameters, arm function, fatigue, and quality of life

(2015) Etienne Allart et al.   JOURNAL OF NEUROLOGY

Effects of dalfampridine on multi-dimensional aspects of gait and dexterity in multiple sclerosis among timed walk responders and non-responders

(2015) A.C. Lo et al.   JOURNAL OF THE NEUROLOGICAL SCIENCES

Improved patient-reported health impact of multiple sclerosis: The ENABLE study of PR-fampridine

(2015) Richard Macdonell et al.   Multiple Sclerosis Journal

Improved patient-reported health impact of multiple sclerosis: The ENABLE study of PR-fampridine

(2015) Richard Macdonell et al.   Multiple Sclerosis Journal

Changes in cognition, arm function and lower body function after Slow-Release Fampridine treatment

(2014) HB Jensen et al.   Multiple Sclerosis Journal

Estimation of the effect of dalfampridine-ER on health utility by mapping the MSWS-12 to the EQ-5D in multiple sclerosis patients

(2013) Brendan L Limone et al.   Health and Quality of Life Outcomes

Long-term effects of dalfampridine in patients with multiple sclerosis

(2013) T. Ruck et al.   JOURNAL OF THE NEUROLOGICAL SCIENCES

Effect of 4-aminopyridine on vision in multiple sclerosis patients with optic neuropathy

(2013) L. Horton et al.   NEUROLOGY

Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria

(2011) Chris H. Polman et al.   ANNALS OF NEUROLOGY

Dalfampridine: a brief review of its mechanism of action and efficacy as a treatment to improve walking in patients with multiple sclerosis

(2011) Jeffrey Dunn et al.   CURRENT MEDICAL RESEARCH AND OPINION

Profiling of a Prescription Drug Library for Potential Renal Drug–Drug Interactions Mediated by the Organic Cation Transporter 2

(2011) Yasuto Kido et al.   JOURNAL OF MEDICINAL CHEMISTRY

A phase 3 trial of extended release oral dalfampridine in multiple sclerosis

(2010) Andrew D. Goodman et al.   ANNALS OF NEUROLOGY

Sustained-release oral fampridine in multiple sclerosis: a randomised, double-blind, controlled trial

(2009) Andrew D Goodman et al.   LANCET